A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)
Clinical trial NCT02110225 · COMPLETED
Trial details
- NCT number
- NCT02110225
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.